Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Return on Sales (2016 - 2025)

Conmed (CNMD) has disclosed Return on Sales for 12 consecutive years, with 0.54% as the latest value for Q3 2021.

  • For the quarter ending Q3 2021, Return on Sales fell 3.0% year-over-year to 0.54%, compared with a TTM value of 0.54% through Sep 2021, changed 0.0%, and an annual FY2025 reading of 0.03%, down 7.0% over the prior year.
  • Return on Sales was 0.54% for Q3 2021 at Conmed, down from 0.55% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.68% in Q4 2017 and bottomed at 0.46% in Q2 2020.
  • Average Return on Sales over 5 years is 0.55%, with a median of 0.55% recorded in 2018.
  • The sharpest move saw Return on Sales rose 17bps in 2017, then fell -14bps in 2018.
  • Year by year, Return on Sales stood at 0.68% in 2017, then decreased by -20bps to 0.55% in 2018, then dropped by -2bps to 0.54% in 2019, then fell by 0bps to 0.54% in 2020, then changed by 0bps to 0.54% in 2021.
  • Business Quant data shows Return on Sales for CNMD at 0.54% in Q3 2021, 0.55% in Q2 2021, and 0.53% in Q1 2021.